Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
Total Valuation
Sumitomo Dainippon Pharma Co has a market cap or net worth of $5.41B. The enterprise value is $674.56B.
Market Cap$5.41B
Enterprise Value$674.56B
Share Statistics
Sumitomo Dainippon Pharma Co has 397,900,150 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding397,900,150
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sumitomo Dainippon Pharma Co’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 7.05%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)7.05%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee80.09M
Profits Per Employee4.75M
Employee Count4,980
Asset Turnover0.54
Inventory Turnover1.63
Valuation Ratios
The current PE Ratio of Sumitomo Dainippon Pharma Co is 4.6. Sumitomo Dainippon Pharma Co’s PEG ratio is -0.11.
PE Ratio4.6
PS Ratio0.73
PB Ratio1.71
Price to Fair Value1.71
Price to FCF83.47
Price to Operating Cash Flow23.67
PEG Ratio-0.11
Income Statement
In the last 12 months, Sumitomo Dainippon Pharma Co had revenue of 398.83B and earned 23.63B in profits. Earnings per share was 59.49.
Revenue398.83B
Gross Profit245.40B
Operating Income28.80B
Pretax Income17.61B
Net Income23.63B
EBITDA56.67B
Earnings Per Share (EPS)59.49
Cash Flow
In the last 12 months, operating cash flow was 29.97B and capital expenditures -6.96B, giving a free cash flow of 23.02B billion.
Operating Cash Flow29.97B
Free Cash Flow23.02B
Free Cash Flow per Share57.85
Dividends & Yields
Sumitomo Dainippon Pharma Co pays an annual dividend of $0.053, resulting in a dividend yield of ―
Dividend Per Share$0.053
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.43
52-Week Price Change323.67%
50-Day Moving Average13.38
200-Day Moving Average8.55
Relative Strength Index (RSI)72.54
Average Volume (3m)230.00
Important Dates
Sumitomo Dainippon Pharma Co upcoming earnings date is Feb 4, 2026, TBA (Confirmed).
Last Earnings DateOct 31, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend DateMar 30, 2023
Financial Position
Sumitomo Dainippon Pharma Co as a current ratio of 1.05, with Debt / Equity ratio of 175.48%
Current Ratio1.05
Quick Ratio0.66
Debt to Market Cap1.05
Net Debt to EBITDA4.98
Interest Coverage Ratio2.13
Taxes
In the past 12 months, Sumitomo Dainippon Pharma Co has paid -6.02B in taxes.
Income Tax-6.02B
Effective Tax Rate-0.34
Enterprise Valuation
Sumitomo Dainippon Pharma Co EV to EBITDA ratio is 10.09, with an EV/FCF ratio of 164.82.
EV to Sales1.43
EV to EBITDA10.09
EV to Free Cash Flow164.82
EV to Operating Cash Flow34.66
Balance Sheet
Sumitomo Dainippon Pharma Co has $38.49B in cash and marketable securities with $262.85B in debt, giving a net cash position of -$224.36B billion.
Cash & Marketable Securities$38.49B
Total Debt$262.85B
Net Cash-$224.36B
Net Cash Per Share-$563.86
Tangible Book Value Per Share-$504.51
Margins
Gross margin is 60.93%, with operating margin of 7.22%, and net profit margin of 5.93%.
Gross Margin60.93%
Operating Margin7.22%
Pretax Margin4.42%
Net Profit Margin5.93%
EBITDA Margin14.21%
EBIT Margin7.80%
Analyst Forecast
The average price target for Sumitomo Dainippon Pharma Co is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―